The origins and development of the National Marrow Donor Program

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

Blood·2001

Characterization of a late promoter from the Streptomyces temperate phage phi C31.

Journal of bacteriology·1996

Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

Clinical transplants·1995

Aspergillus fumigatus keratitis with intraocular invasion in 15-day-old chicks.

Avian diseases·1994

Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

Clinical transplants·1994

Characterization of IgE antibody binding profiles of sera from patients with atopic dermatitis to allergens of the domestic mites Dermatophagoides pteronyssinus and Euroglyphus maynei, using enhanced chemiluminescent immunoblotting.

International archives of allergy and immunology·1992

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Leukemia·2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Leukemia·2026

PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

Leukemia·2026

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Leukemia·2026

Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche.

Leukemia·2026

Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls.

Leukemia·2026

Real‑world implementation of rTMS for depression: a comparative study of Sweden and Japan.

Nordic journal of psychiatry·2026

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

American journal of hematology·2026

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

AIDS (London, England)·2026

Rapid antiretroviral therapy initiation is associated with improved early retention in care and accelerates viral suppression among individuals newly diagnosed with HIV.

AIDS care·2026

Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.

Rheumatology advances in practice·2026

Smartphone-Delivered MBRP and Quality of Life among Individuals With Opioid Use Disorder: A Pilot Before-After Study.

Health science reports·2026

Related Experiment Videos

The origins and development of the National Marrow Donor Program

Related Concept Videos

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

Characterization of a late promoter from the Streptomyces temperate phage phi C31.

Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

Aspergillus fumigatus keratitis with intraocular invasion in 15-day-old chicks.

Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

Characterization of IgE antibody binding profiles of sera from patients with atopic dermatitis to allergens of the domestic mites Dermatophagoides pteronyssinus and Euroglyphus maynei, using enhanced chemiluminescent immunoblotting.

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche.

Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls.

Real‑world implementation of rTMS for depression: a comparative study of Sweden and Japan.

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

Rapid antiretroviral therapy initiation is associated with improved early retention in care and accelerates viral suppression among individuals newly diagnosed with HIV.

Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.

Smartphone-Delivered MBRP and Quality of Life among Individuals With Opioid Use Disorder: A Pilot Before-After Study.

Related Experiment Videos

The origins and development of the National Marrow Donor Program

Related Concept Videos

Related Articles